AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 6c ; Offers Guidance

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.35), $0.06 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $18.3 million.

GUIDANCE:

AVITA Medical, Inc. sees FY2026 revenue of $80-85 million, versus the consensus of $126.5 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
• UnitedHealth Group (UNH) Reiterated at Overweight by Cantor Fitzgerald